1. |
Details of PDMR/person closely associated with them ('PCA') |
a) |
Name |
Mr B McNamara |
b) |
Position/status |
CEO, GSK Consumer Healthcare |
c) |
Initial notification/ amendment |
Initial notification |
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
GlaxoSmithKline plc |
b) |
LEI |
5493000HZTVUYLO1D793 |
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
a) |
Description of the financial instrument |
American Depositary Shares ('ADSs') I SIN: US37733W1053 |
b) |
Nature of the transaction |
Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 13 April 2017 on ADSs held in the Company's 2009 Performance Share Plan. |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
$41.81 |
90.871 |
$41.81 |
454.207 |
$41.81 |
701.005 |
|
d) |
Aggregated information Aggregated volume Price |
1,246.083 $41.81 |
e) |
Date of the transaction |
2017-04-18 |
f) |
Place of the transaction |
n/a |